Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on May 26th, 2023%
Results of a small clinical trial show most patients with melanoma receiving a personalized therapeutic vaccine with an approved immunotherapy reduced at least some of their tumors. . . . → Read More: AI-Designed Cancer Vaccine Shown to Act Against Melanoma
By Alan, on May 25th, 2023%
Interim results from a clinical trial show a drug given as a dissolvable oral film in a lower dose reduces agitation in people with bipolar disorder and schizophrenia. . . . → Read More: Low-Dose Oral Film Reduces Mental Disorder Agitation
By Alan, on May 19th, 2023%
A new challenge competition seeks biomarkers, models, and clinical tests of the factors behind responses to stress conditions in human aging that can stave off frailty or death. . . . → Read More: $60M Challenge Seeks Biomarkers, Models to Counter Aging Stress
By Alan, on May 17th, 2023%
A clinical trial shows a peel-and-stick patch device is as effective as a standard syringe injection in delivering a vaccine that protects against measles and rubella. . . . → Read More: Measles-Rubella Patch Vaccine Shown Effective as Injection
By Alan, on May 12th, 2023%
An organization seeking new uses for today’s drugs and a contract research company aim to increase the number of clinical trials for rare diseases testing already approved drugs. . . . → Read More: Collaboration to Boost Rare Disease Clinical Trials
By Alan, on May 4th, 2023%
The first participant in a clinical trial received a dose of a psychedelic therapy, assessing the experimental compound in people with treatment resistant depression. . . . → Read More: Trial Underway Testing Psychedelic Drug for Depression
By Alan, on May 2nd, 2023%
A genomic analysis of urine samples is shown to predict the most common form of bladder cancer years before symptoms appear. . . . → Read More: DNA Test Detects Early Bladder Cancer in Urine
By Alan, on April 28th, 2023%
A clinical trial shows a light-activated protein from an injected gene improves visual abilities in people with advanced retinitis pigmentosa, an inherited eye disorder. . . . → Read More: Light-Activated Therapy Improves Vision in Inherited Disease Trial
By Alan, on April 27th, 2023%
Ultra-low quantities of an experimental Covid-19 protein vaccine delivered in synthetic cell components are shown in lab animals to generate strong immune responses. . . . → Read More: Low-Dose Covid-19 Vaccine Generates Strong Immune Response
By Alan, on April 26th, 2023%
A study of insurance claims records matching the design of randomized clinical trials shows claims data can in some cases resemble clinical trial results to make causal inferences. . . . → Read More: Real World Evidence Shown to Emulate Some Clinical Trials
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|